Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Konstantinos Roufas"'
Autor:
Maria Marketou, George E. Kochiadakis, Aikaterini Giaouzaki, Katerini Sfiridaki, Stelios Petousis, Fragiskos Maragoudakis, Konstantinos Roufas, Despoina Vougia, John Logakis, Gregory Chlouverakis, Panos E. Vardas
Publikováno v:
Hellenic Journal of Cardiology, Vol 58, Iss 1, Pp 43-48 (2017)
Background: Platelet activation is crucial in the development of stent thrombosis following percutaneous coronary intervention (PCI). We carried out a long-term assessment of multiple factors implicated in the thrombotic process and monitored markers
Externí odkaz:
https://doaj.org/article/e4c27be257c64ec286cc05333050ae39
Autor:
Christos Paliouras, Georgios Aperis, Foteini Lamprianou, Giorgos Ntetskas, Konstantinos Roufas, Polichronis Alivanis
Publikováno v:
Nefrología, Vol 35, Iss 6, Pp 578-581 (2015)
Fabry disease is a rare X-linked lysosomal storage disorder of glycosphingolipids, caused by the partial or complete deficiency of the lysosomal enzyme alpha-galactosidase A (a-Gal A). The missense mutation pN215S usually causes a milder form of the
Externí odkaz:
https://doaj.org/article/23d80a9068c64a5d93e04258fe67731b
Autor:
John Logakis, Fragiskos Maragoudakis, Gregory Chlouverakis, Katerini Sfiridaki, Panos E. Vardas, Konstantinos Roufas, Aikaterini Giaouzaki, Stelios Petousis, Despoina Vougia, Maria E. Marketou, George E. Kochiadakis
Publikováno v:
Hellenic Journal of Cardiology, Vol 58, Iss 1, Pp 43-48 (2017)
Background: Platelet activation is crucial in the development of stent thrombosis following percutaneous coronary intervention (PCI). We carried out a long-term assessment of multiple factors implicated in the thrombotic process and monitored markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f0c455dcbd37744a731e3fb61e418c
https://doi.org/10.1016/j.hjc.2017.01.009
https://doi.org/10.1016/j.hjc.2017.01.009
Autor:
Polichronis Alivanis, Konstantinos Roufas, Georgios Aperis, Giorgos Ntetskas, Christos Paliouras, Foteini Lamprianou
Publikováno v:
Nefrología, Vol 35, Iss 6, Pp 578-581 (2015)
Nefrología (English Edition), Vol 35, Iss 6, Pp 578-581 (2015)
Nefrología (English Edition), Vol 35, Iss 6, Pp 578-581 (2015)
Fabry disease is a rare X-linked lysosomal storage disorder of glycosphingolipids, caused by the partial or complete deficiency of the lysosomal enzyme alpha-galactosidase A (a-Gal A). The missense mutation pN215S usually causes a milder form of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d00cde4311c7dd79fa2910f16be2974
https://doi.org/10.1016/j.nefroe.2015.09.009
https://doi.org/10.1016/j.nefroe.2015.09.009